IS1690B - Aðferð til framleiðslu pyrrol-efnasambanda og milliefni til notkunar við aðferðina - Google Patents

Aðferð til framleiðslu pyrrol-efnasambanda og milliefni til notkunar við aðferðina

Info

Publication number
IS1690B
IS1690B IS4162A IS4162A IS1690B IS 1690 B IS1690 B IS 1690B IS 4162 A IS4162 A IS 4162A IS 4162 A IS4162 A IS 4162A IS 1690 B IS1690 B IS 1690B
Authority
IS
Iceland
Prior art keywords
lower alkyl
amino
formula
aryl
prevention
Prior art date
Application number
IS4162A
Other languages
English (en)
Icelandic (is)
Other versions
IS4162A (is
Inventor
Harris William
Huw Hill Christopher
Lawton Geoffrey
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939309602A external-priority patent/GB9309602D0/en
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of IS4162A publication Critical patent/IS4162A/is
Publication of IS1690B publication Critical patent/IS1690B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
IS4162A 1993-05-10 1994-05-09 Aðferð til framleiðslu pyrrol-efnasambanda og milliefni til notkunar við aðferðina IS1690B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939309602A GB9309602D0 (en) 1993-05-10 1993-05-10 Substituted pyrroles
GB9403249A GB9403249D0 (en) 1993-05-10 1994-02-21 Substituted pyrroles

Publications (2)

Publication Number Publication Date
IS4162A IS4162A (is) 1994-11-11
IS1690B true IS1690B (is) 1998-04-20

Family

ID=26302877

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4162A IS1690B (is) 1993-05-10 1994-05-09 Aðferð til framleiðslu pyrrol-efnasambanda og milliefni til notkunar við aðferðina

Country Status (25)

Country Link
EP (1) EP0624586B1 (ru)
JP (1) JP2668818B2 (ru)
CN (1) CN1048014C (ru)
AT (1) ATE184007T1 (ru)
AU (1) AU678435B2 (ru)
BG (1) BG98761A (ru)
BR (1) BR9401935A (ru)
CA (1) CA2121567A1 (ru)
CZ (1) CZ112894A3 (ru)
DE (1) DE69420310T2 (ru)
DK (1) DK0624586T3 (ru)
ES (1) ES2137281T3 (ru)
FI (1) FI106961B (ru)
GR (1) GR3031901T3 (ru)
HR (1) HRP940287B1 (ru)
HU (1) HU215954B (ru)
IL (1) IL109547A (ru)
IS (1) IS1690B (ru)
LT (1) LT3288B (ru)
LV (1) LV11173B (ru)
NO (1) NO301230B1 (ru)
NZ (1) NZ260475A (ru)
RU (1) RU2141960C1 (ru)
SI (1) SI0624586T1 (ru)
SK (1) SK53594A3 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
RU2147304C1 (ru) * 1993-12-07 2000-04-10 Эли Лилли Энд Компани Бис-индолмалеимидные макроциклические производные, способ их получения (варианты) и фармацевтическая композиция
EP1449529B1 (en) * 1993-12-23 2010-01-27 Eli Lilly And Company Protein Kinase C Inhibitors
DK0695755T3 (da) * 1994-08-04 1999-06-28 Hoffmann La Roche Pyrrolocarbazoler
US5919946A (en) * 1996-03-20 1999-07-06 Eli Lilly And Company Synthesis of indolylmaleimides
KR100499190B1 (ko) * 1996-03-29 2006-04-17 교와 핫꼬 고교 가부시끼가이샤 육모제
US5859261A (en) * 1997-03-20 1999-01-12 Eli Lilly And Company Synthesis of indolylmaleimides
HUP0301431A2 (hu) 2000-07-27 2003-08-28 F. Hoffmann-La Roche Ag. 3-Indolil-4-fenil-1H-pirrol-2,5-dion-származékok, mint glikogén szintáz kináz-3béta inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
ATE335490T1 (de) 2001-10-30 2006-09-15 Novartis Pharma Gmbh Staurosporin-derivate als hemmer der flt3- rezeptor-tyrosinkinase-wirkung
CA2393720C (en) 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
CN100536850C (zh) 2003-08-08 2009-09-09 诺瓦提斯公司 包含星孢素的组合

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3803620A1 (de) * 1988-02-06 1989-08-17 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
DE3833008A1 (de) * 1988-09-29 1990-04-05 Goedecke Ag Pyrrolocarbozol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
MC2096A1 (fr) * 1989-02-23 1991-02-15 Hoffmann La Roche Pyrroles substitues
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles

Also Published As

Publication number Publication date
NO941682L (no) 1994-11-11
SI0624586T1 (en) 1999-12-31
CZ112894A3 (en) 1994-12-15
JPH06329672A (ja) 1994-11-29
RU2141960C1 (ru) 1999-11-27
AU678435B2 (en) 1997-05-29
CA2121567A1 (en) 1994-11-11
EP0624586A1 (en) 1994-11-17
HUT71492A (en) 1995-11-28
GR3031901T3 (en) 2000-02-29
BG98761A (en) 1995-03-31
ES2137281T3 (es) 1999-12-16
IS4162A (is) 1994-11-11
NO301230B1 (no) 1997-09-29
IL109547A0 (en) 1994-08-26
NZ260475A (en) 1996-02-27
IL109547A (en) 1998-07-15
DE69420310D1 (de) 1999-10-07
LTIP1927A (en) 1994-11-25
HU215954B (hu) 1999-03-29
HU9401298D0 (en) 1994-08-29
LV11173A (lv) 1996-04-20
AU6055594A (en) 1994-11-17
FI942158A (fi) 1994-11-11
JP2668818B2 (ja) 1997-10-27
DE69420310T2 (de) 2000-04-13
CN1048014C (zh) 2000-01-05
ATE184007T1 (de) 1999-09-15
CN1103402A (zh) 1995-06-07
BR9401935A (pt) 1995-03-07
SK53594A3 (en) 1995-02-08
DK0624586T3 (da) 2000-03-27
FI942158A0 (fi) 1994-05-10
HRP940287A2 (en) 1996-12-31
EP0624586B1 (en) 1999-09-01
LV11173B (en) 1996-06-20
HRP940287B1 (en) 2000-02-29
FI106961B (fi) 2001-05-15
LT3288B (en) 1995-06-26
NO941682D0 (no) 1994-05-06

Similar Documents

Publication Publication Date Title
IS1690B (is) Aðferð til framleiðslu pyrrol-efnasambanda og milliefni til notkunar við aðferðina
NO20050122L (no) Prodrug av eksitasjonsaminosyrer
DK0773955T3 (da) Hidtil ukendte inhibitorer for thrombin, deres fremstilling og anvendelse
DK1018511T3 (da) Isochromanforbindelser og fremgangsmåde til deres fremstilling
FI913754A (fi) Menetelmä terapeuttisesti käyttökelpoisten 3,4-bis(3-indolyyli)-1H-pyrroli-2,5-dionijohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoiset välituotteet
NO984195L (no) Nye benzofuranonderivater og deres fremstilling
RU94015830A (ru) Замещенные пирролы
AU4452693A (en) Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method ofuse thereof
NO904135L (no) Fremgangsmaate for fremstilling av nye substituerte alkylpiperidiner og deres anvendelse som inhibitorer av kolesterolsyntese.
DE69527854T2 (de) Derivate substituierter amidinonaphthylester
YU19194A (sh) Supstituisani piroli
RS20050514A (en) Compounds having prolyl oligopeptidase inhibitory activity
AU2939700A (en) Synthesis of alpha-amino-alpha',alpha'-dihaloketones and process for the preparation of beta-amino acid derivatives by the use of the same
DE60235119D1 (en) Bipyridinylderivate als hochselektive cyclooxygenase-2-inhibitoren
HUP0300348A2 (hu) Eljárás (aril-imino-metil)-karbamidsav-észterek előállítására